Trials / Completed
CompletedNCT01196923
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- CardioFocus · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact in the treatment of atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopically Guided Ablation | Visually Guided Ablation using EAS-AC |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-03-01
- Completion
- 2012-06-01
- First posted
- 2010-09-09
- Last updated
- 2016-07-27
- Results posted
- 2016-07-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01196923. Inclusion in this directory is not an endorsement.